Comoli P, Labirio M, Basso S, et al. Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication[J]. Blood,2002,99(7):2592-2598.
[3]
Styczynski J, Einsele H, Gil L, et al. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases[J]. Transpl Infect Dis,2009,11(5):383-392.
[4]
Patrick A, Wee A, Hedderman A, et al. High-dose intravenous rituximab for multifocal, monomorphic primary central nervous system posttransplant lymphoproliferative disorder[J]. J Neurooncol,2011,103(3):739-743.
[5]
Tsao L, Hsi E D. The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders[J]. Arch Pathol Lab Med,2007,131(8):1209-1218.
[6]
Martino R, Romero P, Subira M, et al. Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. International Bone Marrow Transplant Registry[J]. Bone Marrow Transplant,1999,24(3):283-287.
[7]
Xu LP, Huang XJ, Liu DH, et al. The clinical research of post-transplant lymphoproliferative disease after allogeneic hemapoietic stem cell transplantation[J]. J Intern Med ,2007(12):996-999.（In Chinese）
Evens A M, Choquet S, Kroll-Desrosiers A R, et al. Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era[J]. Am J Transplant,2013,13(6):1512-1522.
[10]
Choquet S, Oertel S, Leblond V, et al. Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution[J]. Ann Hematol,2007,86(8):599-607.
[11]
Weinstock D M, Ambrossi G G, Brennan C, et al. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development[J]. Bone Marrow Transplant,2006,37(6):539-546.
[12]
Liu QF. Emphasis on research of post-transplant lymphoproliferative disease[J]. J Intern Med , 2007(12):977-978.（In Chinese）
